Sprankle; Kelly G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sprankle; Kelly G..The latest application filed is for "imidazolothiazole compounds for the treatment of disease".

Company Profile

0.17.14

Sprankle; Kelly G. - Vista CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
RAF kinase modulator compounds and methods of use thereof Grant 10,053,430 - Abraham , et al. August 21, 2	2018-08-21
Imidazolothiazole Compounds For The Treatment Of Disease App 20170348320 - Bhagwat; Shripad ; et al.	2017-12-07
Raf Kinase Modulator Compounds And Methods Of Use Thereof App 20170298029 - ABRAHAM; Sunny ; et al.	2017-10-19
RAF kinase modulator compounds and methods of use thereof Grant 9,730,937 - Abraham , et al. August 15, 2	2017-08-15
Raf Kinase Modulator Compounds And Methods Of Use Thereof App 20160199375 - Abraham; Sunny ; et al.	2016-07-14
RAF kinase modulator compounds and methods of use thereof Grant 9,320,739 - Abraham , et al. April 26, 2	2016-04-26
Raf Kinase Modulator Compounds And Methods Of Use Thereof App 20150246042 - Abraham; Sunny ; et al.	2015-09-03
Imidazolothiazole Compounds For The Treatment Of Disease App 20150126505 - Bhagwat; Shripad ; et al.	2015-05-07
RAF kinase modulator compounds and methods of use thereof Grant 8,969,587 - Abraham , et al. March 3, 2	2015-03-03
Imidazolothiazole Compounds For The Treatment Of Disease App 20140243525 - Bhagwat; Shripad ; et al.	2014-08-28
Raf Kinase Modulator Compounds And Methods Of Use Thereof App 20140045868 - Abraham; Sunny ; et al.	2014-02-13
RAF kinase modulator compounds and methods of use thereof Grant 8,618,289 - Abraham , et al. December 31, 2	2013-12-31
Imidazolothiazole compounds for the treatment of disease Grant 8,557,810 - Bhagwat , et al. October 15, 2	2013-10-15
Imidazolothiazole Compounds For The Treatment Of Disease App 20120129850 - Bhagwat; Shripad ; et al.	2012-05-24
Method of using imidazolothiazole compounds for the treatment of disease Grant 8,129,374 - Bhagwat , et al. March 6, 2	2012-03-06
Raf Kinase Modulator Compounds And Methods Of Use Thereof App 20110118245 - Abraham; Sunny ; et al.	2011-05-19
Method Of Using Imidazolothiazole Compounds For The Treatment Of Disease App 20100298313 - Bhagwat; Shripad ; et al.	2010-11-25
Imidazolothiazole compounds for the treatment of disease Grant 7,820,657 - Bhagwat , et al. October 26, 2	2010-10-26
Process For The Synthesis Of 2'-O-Substituted Pyrimidines And Oligomeric Compounds Therefrom App 20070232798 - Cook; Phillip Dan ; et al.	2007-10-04
Imidazolothiazole compounds for the treatment of disease App 20070232604 - Bhagwat; Shripad ; et al.	2007-10-04
Processes for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom App 20050059815 - Cook, Phillip Dan ; et al.	2005-03-17
Amine compounds and combinatorial libraries comprising same Grant 6,750,344 - Swayze , et al. June 15, 2	2004-06-15
Process for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom Grant 6,642,367 - Cook , et al. November 4, 2	2003-11-04
Process for the synthesis of 2' -O-substituted pyrimidines and oligomeric compounds therefrom App 20030050454 - Cook, Phillip Dan ; et al.	2003-03-13
Amine compounds and combinatorial libraries comprising same Grant 6,316,626 - Swayze , et al. November 13, 2	2001-11-13
Process for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom Grant 6,222,025 - Cook , et al. April 24, 2	2001-04-24
Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions Grant 6,166,197 - Cook , et al. December 26, 2	2000-12-26
Process for the synthesis of 2'-O-substituted pyrimidines Grant 5,861,493 - Cook , et al. January 19, 1	1999-01-19
Process for the synthesis of 2'-O-substituted pyrimidines Grant 5,760,202 - Cook , et al. June 2, 1	1998-06-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.